Skip to content
OpenCapital
Get started
Income StatementBalance SheetCash FlowSegments
Edwards Lifesciences logo

Edwards Lifesciences Balance Sheet Statement

Assets, liabilities, and shareholders' equity

Edwards Lifesciences holds $13.3B in total assets. Shareholders' equity is $10.3B against $702.9M in total debt. Cash and equivalents total $2.4B. The current ratio is 4.42 and debt-to-equity is 0.068. Based on the Q1 2026 filing.

Total Assets$13.3BTotal Stockholders Equity$10.3BLong Term Debt$598.5MCash And Equivalents$2.4BTotal Current Assets$6.2BTotal Current Liabilities$1.4B
Latest FilingQ1 2026
Report Date2026-05-06
Market Cap$49.4B
P/E Ratio45.05
ROE10.72%

Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accounts payable$197.4M$172.4M$162.1M$165M$227.5M$181.1M
Accrued Manufacturing Costs$358.6M$232.8M$352.7M$437.4M$467.5M$265.4M
Accrued and other liabilities (Note 2)$1.3B$1.2B$1.2B$1.4B$1.6B$1.2B
Accrued Income Taxes, Current$286.6M$297.4M$146.3M$129.5M$192.5M$204.9M
Derivative Liability, Current$8.3M$10.5M$54.2M$34.5M$25.3M$7.6M
Compensation and benefits$358.6M$232.8M$352.7M$437.4M$467.5M$265.4M
Derivative Liabilities - Fair Value$8.3M$10.5M$54.2M$34.5M$25.3M$7.6M
Income taxes payable$1.3M$51.2M-$240.4M-$10.2M—$41.9M
Operating lease liabilities, current$23.4M$23.7M$25.9M$26.8M$24.5M$24.3M
Total current liabilities$1.5B$1.4B$1.4B$1.6B$1.8B$1.4B

Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accounts receivable, net$609.1M$669.2M$697M$693.3M$659.6M$775.7M
Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year)—$706M$745.4M$1.1B—$1.2B
AFS and Trading Securities - Unrealized Loss Position (>=12 Months)$214.2M$146.4M$116.9M$90.4M$69.8M$53.2M
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value$8.4M$8M$8.7M$11.3M$81.8M$435.3M
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Fair Value$214.2M$146.4M$116.9M$90.4M$69.8M$53.2M
AFS and Trading Securities - Unrealized Loss Position Fair Value$222.6M$154.4M$125.6M$101.7M$151.6M$488.5M
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value$8.4M$8M$8.7M$11.3M$81.8M$435.3M
Allowance for Doubtful Accounts$11.6M$12.6M$12.7M$12.6M$15M$15.6M
Cash and cash equivalents$3.1B$3.1B$3.3B$2.7B$2.9B$2.4B
Finished goods$609.4M$594.5M$630.5M$642.2M$676.7M$674.4M
Other current assets$347.6M$304.5M$314.4M$323.4M$339.3M$329.5M
Other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025)$118.3M$82.7M$205.6M$199.5M$252.5M$197.3M
Derivative Assets - Fair Value$34.7M$26.6M$3.1M$5.1M$5.8M$14.2M
Derivative assets————$21.4M$40.3M
Raw materials$241.1M$259.2M$249.8M$222.8M$196.6M$202.4M
Work in process$236.2M$260.2M$261.4M$275.9M$252.9M$242.2M
Inventories$1.1B$1.1B$1.1B$1.1B$1.1B$1.1B
Prepaid expenses and other current assets$101.6M$99.7M$97.7M$95.7M$93.3M$91.3M
Restricted cash————$500K$1M
Total current assets$6.3B$6.2B$6.6B$6.4B$6.7B$6.2B

Equity

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss$5.2M$3.8M$2.7M$1.9M$1.2M$1.1M
Accumulated other comprehensive income (loss)-$244.5M-$254.5M-$264.1M-$250.4M-$238.3M-$221.3M
Additional paid-in capital$2.6B$2.7B$2.8B$2.7B$2.8B$2.8B
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March&#160;31, 2026 and December&#160;31, 2025, respectively$654.8M$655.9M$657.6M$658.2M$658.7M$660M
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding$0$0$0$0$0$0
Investments - Gross Unrealized Losses$222.6M$154.4M$125.6M$101.7M$151.6M$488.5M
Retained earnings$13.2B$13.5B$13.9B$14.1B$14.2B$14.6B
Total liabilities and stockholders' equity$13.1B$13B$13.5B$13.3B$13.7B$13.3B
Total stockholders' equity$10B$10.1B$10.5B$10.2B$10.3B$10.3B
Treasury stock$6.2B$6.5B$6.5B$7B$7.1B$7.5B

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Cumulative Cost Basis$1B$827.8M$839.4M$1.2B$1.3B$1.2B
Gross Assets/Liabilities————$27M$8.1M
Threshold of disclosing material environmental legal proceedings—$1M$1M$1M—$1M
Property, payroll, and other taxes$88.1M$79.3M$78.5M$93.5M$84.9M$89.4M
Legal and insurance accrual$26.8M$28M$26.4M$104.9M$164.2M$75.9M
Accrued rebates$139.3M$118.9M$143.2M$158.2M$156.6M$144.4M
Acquisition options$147.1M$150.3M$111.5M$129.9M$125.9M$79.3M
Allowance for doubtful accounts$11.6M$12.6M$12.7M$12.6M$15M$15.6M
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax$5.3M$3.9M$2.8M$2M$1.4M$1.6M
Gross Unrealized Gains$200K$100K$100K$200K$300K$0
Total$1B$827.8M$839.4M$1.2B$1.3B$1.2B
1&#160;Year&#160;or&#160;Less—$704.9M$744.7M$1.1B—$1.2B
Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost—$75M$65.5M$57.1M—$45M
Available for sale investments$1B$824M$836.7M$1.2B$1.3B$1.2B
Business Combination, Contingent Consideration, Liability, Current————$0$7.5M
Common stock, par value (in dollars per share)$1.00$1.00$1.00$1.00$1.00$1.00
Common stock, shares authorized (in shares)1.1B1.1B1.1B1.1B1.1B1.1B
Common stock, shares issued (in shares)654.8M655.9M657.6M658.2M658.7M660M
Common Stock, Shares, Outstanding588.6M586.2M587.9M580.7M580.7M577M
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss$5.2M$3.8M$2.7M$1.9M$1.2M$1.1M
Less than 12 months$8.4M$8M$8.7M$11.3M$81.8M$435.3M
12 months or more$214.2M$146.4M$116.9M$90.4M$69.8M$53.2M
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss$100K$100K$100K$100K$200K$500K
Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss$5.3M$3.9M$2.8M$2M$1.4M$1.6M
Debt Securities, Available-for-Sale, Unrealized Loss Position$222.6M$154.4M$125.6M$101.7M$151.6M$488.5M
Decrease in Unrecognized Tax Benefits is Reasonably Possible$319.9M$332.7M$346.6M$362.6M$377M$391.9M
Deferred compensation plan assets————$167M$155.5M
Derivatives$34.7M$26.6M$3.1M$5.1M$5.8M$14.2M
Derivative Liability————$27M$8.1M
Unfavorable contract liability$53.7M$46.2M$36.8M$33.2M$27.2M$22.8M
Unrecognized compensation cost related to non-vested awards—$239.3M$346.1M$324.1M—$264.3M
Equity method investments (Note 11)$34.8M$33.1M$34.6M$34M$34.7M$35M
Fair Value Liabilities Measured On Recurring Basis Obligations————$2M$9.9M
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value$21.5M$22.6M$22.6M$8.1M$8.1M$16M
1&#160;Year&#160;or&#160;Less—$53M$44.7M$46.8M—$39.1M
Instruments not due at a single maturity date—$0$0$0—$0
Held to maturity, Mortgage backed securities, Fair Value—$0$0$0—$0
Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost—$53M$44.7M$46.8M—$39.1M
Income taxes receivable$293.9M$297.8M$297.8M$303.9M$314.8M$400.1M
Estimated litigation liability$10.5M——$85.5M$146.2M$57.3M
Other accrued liabilities$96.4M$85.1M$85.3M$104.4M$177.5M$179.4M
Construction materials and aviation spare parts$181.7M$200.3M$216.7M$216.3M$225.1M$230.2M
Other liabilities————$6.1M$6.1M
Notes and other receivables$129.3M$147.8M$205.6M$227.3M$173.7M$137.2M
Preferred Stock, Par or Stated Value Per Share$0.01$0.01$0.01$0.01$0.01$0.01
Preferred Stock, Shares Authorized50M50M50M50M50M50M
Preferred Stock, Shares Outstanding000000
Prepaid expenses$121M$111.3M$110M$125.2M$135M$135.7M
Research and development accruals$74.1M$74.9M$74.4M$75.3M$69.2M$69.8M
Restructuring Reserve$20.1M$14M$10.3M$6.6M$13.3M$11.4M
Severance accrual, current$27.4M$22M$19.9M$19.6M$23.4M$23.1M
Liability under transition services agreement$0$66M$60.3M$84.4M$123.4M$113.4M
Treasury stock, shares (in shares)66.2M69.7M69.7M77.5M78M83M
Unrecognized tax benefits$678.8M$700.1M$722.1M$746.9M$767.4M$792.1M
Amount that if recognized, would affect the effective tax rate or regulatory liability$358.9M$367.4M$375.5M$384.3M$390.4M$400.2M
Stated Maturities—$73.1M$64M$55.9M—$44.2M

Non-Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Deferred Tax Assets and Other Non-Current Assets$721.6M$742.7M$743M$784.8M$730.2M$738.9M
Derivative Assets, Non-Current$34.7M$26.6M$3.1M$5.1M$5.8M$14.2M
Equity Securities Without Readily Determinable Fair Value - Cumulative Downward Adjustments—$6.2M$6.2M$7M—$7.9M
Equity Securities Without Readily Determinable Fair Value - Cumulative Upward Adjustments—$9.3M$9.3M$9.4M—$9.4M
Goodwill$1.8B$1.8B$1.8B$1.8B$1.8B$1.8B
Held-to-Maturity Debt Securities - Fair Value—$53M$44.7M$46.8M—$39.1M
Equity securities$5.5M$5.6M$5.1M$6.1M$7.1M$20.7M
Investments - Amortized Cost Basis$1B$827.8M$839.4M$1.2B$1.3B$1.2B
Net Investment in Lease$98.2M$96.9M$99M$96.5M$102.7M$99.3M
Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss—$53M$44.7M$46.8M—$39.1M
Deferred tax assets$992.1M$1B$1.1B$1.1B$1.1B$1.1B
Other intangible assets&#8212;net$1.2B$1.2B$1.2B$1.1B$1.1B$1.2B
Investments$159.4M$158.8M$206.5M$207.9M$227.3M$241.5M
Investments$307.9M$277.9M$298.5M$274.7M$278.6M$285.6M
Operating lease right-of-use assets$98.2M$96.9M$99M$96.5M$102.7M$99.3M
Other non-current assets$721.6M$742.7M$743M$784.8M$730.2M$738.9M
Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)$930.7M$757.9M$789.4M$1.2B$1.3B$1.2B
Operating Lease Right-of-Use Assets in Other Assets$98.2M$96.9M$99M$96.5M$102.7M$99.3M
Other non-current assets$15M$20.5M$27.3M$22.9M$16.7M$16.8M
Property and equipment, net$1.7B$1.7B$1.7B$1.7B$1.8B$1.8B
Software and Technology Licenses, Net$721.6M$742.7M$743M$784.8M$730.2M$738.9M
Total assets$13.1B$13B$13.5B$13.3B$13.7B$13.3B

Non-Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Long-term debt$597.7M$597.8M$598M$598.2M$598.3M$598.5M
Liability For Uncertain Tax Positions Noncurrent$384.6M$402.6M$421.6M$442.9M$502.7M$555.4M
Accrued litigation$73.8M$87.5M$77.3M$64.8M$50M$0
Operating lease liabilities, non-current$78.9M$77.9M$78.7M$75.3M$82.6M$80.1M
Other non-current liabilities$373.3M$357.6M$379.2M$362.6M$362.3M$350.7M
Total liabilities$3B$2.8B$2.9B$3.1B$35.1M$24.1M